The drug, elagolix — now marketed as Orilissa — is made by AbbVie in partnership with Neurocrine Biosciences, and it's taken as a daily pill. It's the ...
News
- A new treatment for a condition that can feel like tiny people skating on razor blades in your ...
- Eli Lilly tops 2Q earnings, guidance expectations
The drugmaker swung to a loss of $259.9 million, or 25 cents per share, during the quarter on charges related to the acquisition of Armo BioSciences ...
- Research shows a promising new class of antibodies protects against HIV-1 infection
San Antonio, Texas (July 24, 2018) - A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the ...
- Crackdown feared as Russian grad school faces govt penalty
"They are closing down independent intellectual centers," said Mikhail Gelfand, a biotechnology professor at the Higher School of Economics in ...
- RELLIS Recollections: Baboons, bovines and bees: A part of RELLIS history, too
... the Southwestern Foundation for Research and Education in San Antonio. ... vice chancellor for the A&M College of Agriculture and Life Sciences.